ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Puma Biotechnology Inc

Puma Biotechnology Inc (PBYI)

2.97
-0.05
(-1.66%)
終了 1月19日 6:00AM
3.00
0.03
(1.01%)
取引時間後: 9:43AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
3.00
買値
2.81
売値
3.91
出来高
545,060
2.94 日の範囲 3.07
2.225 52 週間の範囲 7.73
時価総額
前日終値
3.02
始値
3.03
最終取引時間
財務取引量
US$ 1,634,491
VWAP
2.9987
平均取引量 (3 か月)
608,285
発行済株式数
49,087,684
配当利回り
-
PER
6.73
1 株当たり利益 (EPS)
0.44
歳入
235.64M
純利益
21.59M

Puma Biotechnology Inc について

Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357.

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Puma Biotechnology Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker PBYI. The last closing price for Puma Biotechnology was US$3.02. Over the last year, Puma Biotechnology shares have traded in a share price range of US$ 2.225 to US$ 7.73.

Puma Biotechnology currently has 49,087,684 shares in issue. The market capitalisation of Puma Biotechnology is US$148.24 million. Puma Biotechnology has a price to earnings ratio (PE ratio) of 6.73.

PBYI 最新ニュース

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on January 2, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement...

Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines®...

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on December 2, 2024, the Compensation Committee of Puma’s Board of Directors approved the grant of an...

Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the initiation of its ALISertib in CAncer (ALISCA™-Breast1) Phase II trial (PUMA-ALI-1201; NCT06369285) of...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.51-14.52991452993.513.62.968019643.11629521CS
40.248.695652173912.764.062.738812633.24536207CS
120.27.142857142862.84.062.326082853.09242947CS
26-0.97-24.43324937033.974.132.2254461843.03009682CS
52-2.58-46.23655913985.587.732.2254875524.0262322CS
1560.3513.20754716982.657.731.63730203.57263918CS
260-5.95-66.48044692748.95151.65279406.99996639CS

PBYI - Frequently Asked Questions (FAQ)

What is the current Puma Biotechnology share price?
The current share price of Puma Biotechnology is US$ 3.00
How many Puma Biotechnology shares are in issue?
Puma Biotechnology has 49,087,684 shares in issue
What is the market cap of Puma Biotechnology?
The market capitalisation of Puma Biotechnology is USD 148.24M
What is the 1 year trading range for Puma Biotechnology share price?
Puma Biotechnology has traded in the range of US$ 2.225 to US$ 7.73 during the past year
What is the PE ratio of Puma Biotechnology?
The price to earnings ratio of Puma Biotechnology is 6.73
What is the cash to sales ratio of Puma Biotechnology?
The cash to sales ratio of Puma Biotechnology is 0.62
What is the reporting currency for Puma Biotechnology?
Puma Biotechnology reports financial results in USD
What is the latest annual turnover for Puma Biotechnology?
The latest annual turnover of Puma Biotechnology is USD 235.64M
What is the latest annual profit for Puma Biotechnology?
The latest annual profit of Puma Biotechnology is USD 21.59M
What is the registered address of Puma Biotechnology?
The registered address for Puma Biotechnology is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Puma Biotechnology website address?
The website address for Puma Biotechnology is www.pumabiotechnology.com
Which industry sector does Puma Biotechnology operate in?
Puma Biotechnology operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

PBYI Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock